243 filings
Page 7 of 13
8-K
q3d97 vq9encgh
26 Jul 18
Entry into a Material Definitive Agreement
5:29pm
8-K
5kkqiqqco6d l7z1
10 Jul 18
Other Events
12:57pm
8-K
k3pvd74 ze
29 Jun 18
CytoSorbents Added to the Russell 2000 and Russell 3000 Indexes
12:51pm
8-K
fi0fihxuzsj79z39t5
14 Jun 18
Other Events
12:00am
8-K
5m17dk sq
8 Jun 18
CytoSorbents to Present at the Jefferies 2018 Global Healthcare Conference
1:22pm
8-K
xqpir6fh5tx
7 Jun 18
Submission of Matters to a Vote of Security Holders
9:44pm
8-K
u5axw
24 May 18
Other Events
12:00am
8-K
79a5v 85h
9 May 18
CytoSorbents Reports Strong First Quarter 2018 Financial Results
12:00am
8-K
ojun5stlyz5pu
4 Apr 18
Extends the interest only period of the existing $10M debt by 18 months and adds the option for an additional $5M in debt
12:00am
8-K
57vajkhbztbe sf
20 Mar 18
Departure of Directors or Certain Officers
12:00am
8-K
wqp5sgjmgabj0
14 Mar 18
Full Year 2017 and Q4 2017 Earnings and Operating Results Conference Call
12:00am
8-K
1j3npw psg3w
5 Mar 18
Departure of Directors or Certain Officers
12:00am
8-K
8wg7525d
9 Jan 18
Full Year 2017 Results and Issues Stockholder Letter
12:00am
8-K
sw12drjx4kpp8m jfb
26 Dec 17
CytoSorbents Achieves Key Milestone with FDA Approval of the U.S. REFRESH 2 Pivotal Cardiac Surgery Trial IDE Application
12:00am
8-K
959xaa vx
13 Nov 17
CytoSorbents Continues Strong Trajectory of Growth in the Third Quarter 2017
12:00am
8-K
qfbv3n n5
9 Aug 17
CytoSorbents Reports Record Quarterly Total Revenue and Product Sales in the Second Quarter 2017
12:00am
8-K
0mk9oc e8696awjtp
6 Jul 17
CytoSorbents Receives Additional $5 Million in Non-Dilutive Debt Financing from Bridge Bank
12:00am
8-K
2amhlzs f3s8
7 Jun 17
Submission of Matters to a Vote of Security Holders
12:00am
8-K
mnu bbpbxakk6d7o
30 May 17
Dr. Eric R. Mortensen, M.D., Ph.D., Clinical Trial Veteran, Joins CytoSorbents as Chief Medical Officer
12:00am
8-K
40s6p15s900iwgxfsvn
12 May 17
CytoSorbents Reports First Quarter 2017 Financial Results
12:00am